REVANCE THERAPEUTICS INC shareholders Q3 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CENTAURUS FINANCIAL, INC. 24,527$2810.02%
GREAT LAKES ADVISORS, LLC 222,077$2,547,2230.02%
PROFUND ADVISORS LLC 34,961$401,0030.02%
Caption Management, LLC 121,900$1,398,1930.02%
NOTTINGHAM ADVISORS, INC. 11,979$137,3990.02%
Cubist Systematic Strategies, LLC 220,213$2,525,8440.02%
DAYMARK WEALTH PARTNERS, LLC 24,000$275,2800.02%
Schonfeld Strategic Advisors LLC 201,634$2,312,7410.02%
MARSHALL WACE, LLP 713,638$8,185,4290.02%
Engineers Gate Manager LP 38,372$440,1270.02%
CIBC Asset Management Inc 326,707$3,747,3290.02%
Assenagon Asset Management S.A. 414,055$4,749,2110.02%
PUBLIC SECTOR PENSION INVESTMENT BOARD 176,000$2,018,7200.01%
BLAIR WILLIAM & CO/IL 326,306$3,742,7300.01%
Centiva Capital, LP 50,000$573,5000.01%
Freestone Capital Holdings, LLC 18,020$206,6890.01%
BALYASNY ASSET MANAGEMENT L.P. 469,849$5,389,1680.01%
Accredited Investors Inc. 12,845$147,3320.01%
Perfromance Wealth Partners, LLC 18,500$212,1950.01%
JENNISON ASSOCIATES LLC 997,616$11,442,6560.01%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.